3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
2
Phase 3
1
Phase 2/3
1
Phase 1
1
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Tumor-Agnostic
1
Conditions
Rectal Neoplasms
3
Stomach Neoplasms
2
Colorectal Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Skin Neoplasms
1
Sarcoma, Ewing
1
Radiation Injuries
1
Postoperative Complications
1
Pilonidal Sinus
1
Osteosarcoma
1
Neoplasms
1
Lymphatic Metastasis
1
Low Anterior Resection Syndrome
1
Gestational Trophoblastic Disease
1
Fatigue
1
Esophageal Squamous Cell Carcinoma
1
Esophageal Neoplasms
1
Carcinoma, Squamous Cell
1
Carcinoma
1
Breast Neoplasms
1
Interventions
Radiotherapy, Intensity-Modulated
3
Cisplatin
3
Radiotherapy
2
Radiation
2
Platinum
2
Magnetic Resonance Spectroscopy
2
Immunoglobulin G
2
Disulfides
2
Cetuximab
2
1,2-diaminocyclohexaneplatinum II citrate
2
(225)Ac-DOTA-c(RGDyK)
2
menatetrenone
1
durvalumab
1
atezolizumab
1
Surgical Procedures, Operative
1
Specimen Handling
1
Photochemotherapy
1
Neck Dissection
1
Irinotecan
1
Gemcitabine
1
Endoscopy
1
Docetaxel
1
Carboplatin
1
Bevacizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2/3
×
Carcinoma
×
Surgical Procedures, Operative
×
Clear all
NCT05144100
2021-12-03
SCOPE
Tata Memorial Centre
Phase 2/3
Not yet recruiting
498 enrolled